← Back to patent-cliff list
CAS 86-95-3
quinoline-2,4-diol
Codes: CD-11301-001
Application context (from source-drug indications)
Bladder cancerResiquimodMelanomaResiquimodCutaneous T-cell lymphomaResiquimod
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Resiquimod | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
quinoline-2,4-diol→3-nitroquinoline-2,4-diol→2,4-dichloro-3-nitroquinoline→1-amino-2-methylpropan-2-ol→1-((2-chloro-3-nitroquinolin-4-yl)amino)-2-methylpropan-2-ol→1-((3-amino-2-chloroquinolin-4-yl)amino)-2-methylpropan-2-ol→2-ethoxyacetyl chloride→N-(2-chloro-4-((2-hydroxy-2-methylpropyl)amino)quinolin-3-yl)-2-ethoxyacetamide→2,2-dimethyloxirane
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.